Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.69B | $2.37B | +13.30% |
Cost of Revenue | $342.6M | $266.9M | +28.36% |
Operating Income | $1.14B | $779M | +46.28% |
Net Income | $1.1B | $699.8M | +57.13% |
EPS (Basic) | $4.26 | $2.72 | +56.62% |
EPS (Diluted) | $4.21 | $2.69 | +56.51% |
SG&A Expense | $342.7M | $241.1M | +42.14% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $23.92B | $18.97B | +26.05% |
Current Assets | $13.29B | $12.97B | +2.49% |
Total Liabilities | $5.37B | $4.54B | +18.25% |
Current Liabilities | $3.8B | $3.03B | +25.43% |
Stockholders' Equity | $18.55B | $14.43B | +28.51% |
Cash & Equivalents | $9.16B | $9.29B | -1.42% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.31B | $899.9M | +45.19% |
Investing Cash Flow | $-2.14B | $-1.83B | -16.51% |
Financing Cash Flow | $-357.5M | $-294.7M | -21.31% |
Share Buybacks | $131.2M | $132.8M | -1.20% |
D&A | $53.5M | $38.8M | +37.89% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 42.4% | 32.8% | +9.55% |
Net Margin | 40.9% | — | — |
ROE | 5.9% | — | — |
ROA | 4.6% | — | — |
Current Ratio | $3.501 | — | — |
Debt to Equity | $0.29 | — | — |
Other companies in Biotechnology